[A new method of studying adrenergic effects: the use of an association of desipramine-pyrogallol for the revelation of adrenergic mechanisms in vivo].
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002395:Catecholamines; D002396:Catechols / Q000037:antagonists & inhibitors; D002415:Cats; D003891:Desipramine / Q000494:pharmacology*; D004357:Drug Synergism; D005260:Female; D006632:Histamine / Q000494:pharmacology; D008297:Male; D009541:Nictitating Membrane / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011748:Pyrogallol / Q000494:pharmacology*; D012701:Serotonin / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology*; D014166:Transferases / Q000037:antagonists & inhibitors
D002395:Catecholamines; D002396:Catechols; D013566:Sympathomimetics; D011748:Pyrogallol; D012701:Serotonin; D006632:Histamine; D014166:Transferases; D003891:Desipramine; D009638:Norepinephrine; D010646:Phentolamine
Une nouvelle méthode d'étude de l'adrénergie: l'utilisation de l'association désipramine-pyrogallol pour la révélation de mécanismes adrénergiques "in vivo".